Dr. Ibukun Odutola
DIL HealthTech Ventures LLC is a Delaware limited liability company and an emerging venture investment firm dedicated to investing in exceptional early-stage companies founded or led by women who are building transformative technologies with the potential to improve lives, strengthen industries, and solve some of the world's most pressing challenges.
DIL HealthTech Ventures is an emerging, woman-led venture capital firm investing in the next generation of category-defining companies transforming healthcare, artificial intelligence, and frontier technologies. We partner with visionary founders building enterprise-grade solutions that address some of the world's most significant challenges while creating scalable, venture-backed businesses with global commercial potential.
Our investment strategy focuses on early-stage companies developing breakthrough innovations across AI infrastructure, vertical AI, robotics, digital health, women's health, clinical intelligence, biotechnology, medical devices, bioengineering, aerospace technologies, autonomous systems, cybersecurity, climate resilience, translational oncology, therapeutics, diagnostics, and other frontier technologies. We believe these sectors represent the future of healthcare, industry, and human advancement.
Fund I is intentionally designed to allocate approximately 80% of its capital to women founders building technology companies, reflecting our conviction that exceptional women entrepreneurs remain one of the most overlooked opportunities in venture capital. The remaining capital will be invested in exceptional founders whose vision and innovation strongly align with our investment thesis.
Beyond providing capital, DIL HealthTech Ventures offers founders strategic guidance, clinical expertise, operational support, and access to a growing network of healthcare executives, investors, researchers, and industry partners. Our mission is to back technically exceptional founders solving meaningful global problems while generating top-tier venture returns for our limited partners.
We believe the future will be built by founders creating intelligent infrastructure—not incremental software—and DIL HealthTech Ventures is committed to investing in the companies defining that future.
Thesis
At DIL HealthTech Ventures, we believe the next generation of category-defining companies will emerge from founders building enterprise-grade technologies that transform healthcare, intelligence, infrastructure, and human capability. We invest in scalable innovations across AI infrastructure, vertical AI, robotics, digital health, women’s health, clinical intelligence, biotechnology, medical devices, bioengineering, aerospace technologies, autonomous systems, cybersecurity, climate resilience, translational oncology, therapeutics, diagnostics, and other breakthrough frontier technologies with global commercial potential. We intentionally allocate approximately 80% of our capital to women founders building technology companies, while remaining open to exceptional founders whose vision and innovation align with our investment thesis. Our conviction is that diverse technical leadership, deep domain expertise, and disciplined execution will create the next generation of enduring, market-defining companies while delivering exceptional long-term returns for our limited partners.
We invest in early-stage companies founded or led by women developing transformative technologies in:
- Health Technology (HealthTech)
- Artificial Intelligence & Vertical AI
- Robotics & Autonomous Systems
- Aerospace & NASA-Related Innovation
- Biotechnology & Bioengineering
- Diagnostics & Medical Devices
- Digital Health & Clinical Infrastructure
- Deep Technology
- Translational Oncology & Therapeutics
- Frontier Technologies with Healthcare Applications
We are particularly interested in innovations that improve healthcare delivery, strengthen clinical infrastructure, advance scientific discovery, enhance safety, expand access to care, and address significant unmet needs across society.
At DIL HealthTech Ventures, we invest in founders before they become industry leaders. We seek entrepreneurs with bold ideas, defensible technologies, and the determination to solve complex problems through innovation.
Beyond capital, we provide strategic guidance, industry expertise, mentorship, and access to a growing network of healthcare leaders, technology innovators, investors, and strategic partners to help accelerate company growth.
Despite producing groundbreaking innovations across healthcare, engineering, AI, and deep technology, women founders continue to receive a disproportionately small share of venture capital funding. We believe closing this funding gap represents both a significant investment opportunity and a catalyst for transformative innovation.
By investing in women building the next generation of technologies, we aim to create a stronger innovation ecosystem while generating exceptional outcomes for entrepreneurs, investors, and society.
DIL HealthTech Ventures was founded by
Dr. Ibukun Odutola, DNP, PMHNP-BC, a healthcare executive, psychiatric mental health nurse practitioner, AI entrepreneur, and Founder of
Sentinel AI. Her clinical expertise and experience building AI-powered healthcare technologies provide a differentiated perspective in evaluating innovative companies at the intersection of healthcare, artificial intelligence, and frontier technology.
We are actively building relationships with visionary founders, strategic partners, healthcare organizations, limited partners, family offices, and mission-aligned investors who share our commitment to advancing women-led innovation.
Together, we are investing in the women building the future.